Sarissa Capital Management LP Long-Term Concentrated

Location: Greenwich, CT

CIK: 0001577524 · Show all filings

Period: Q2 2015 (← Previous) (Next →)

Filing Date: Aug 14, 2015

Total Value: $435M (100.0% shares, 0.0% debt)

Holdings (16)

— ARIAD PHARMACEUTICALS INC 24.5%

Value $106M Shares 12,850,000 Est. Cost $6.73 Unrealized —

ABBV ABBVIE INC. 24.4%

Value $106M Shares 1,580,000 Est. Cost $38.85 Unrealized +9.0%

DGX QUEST DIAGNOSTICS INC 9.6%

Value $41.7M Shares 575,000 Est. Cost $46.05 Unrealized +29.7%

— MEDICINES CO 9.0%

Value $38.96M Shares 1,361,900 Est. Cost $28.08 Unrealized —

— AEGERION PHARMACEUTICALS INC 8.9%

Value $38.64M Shares 2,036,829 Est. Cost $24.76 Unrealized —

AMGN AMGEN INC 7.1%

Value $30.7M Shares 200,000 Est. Cost $104.63 Unrealized +12.4%

MRK MERCK & CO INC NEW 5.2%

Value $22.77M Shares 400,000 Est. Cost $31.29 Unrealized +28.6%

— INTRA CELLULAR THERAPIES INC 2.6%

Value $11.5M Shares 360,000 Est. Cost $16.06 Unrealized —

— APRICUS BIOSCIENCES INC 2.6%

Value $11.16M Shares 6,524,505 Est. Cost $1.73 Unrealized —

— REPROS THERAPEUTICS INC 1.9%

Value $8.096M Shares 1,132,367 Est. Cost $16.90 Unrealized —

— VIVUS INC 1.4%

Value $6.075M Shares 2,573,943 Est. Cost $9.08 Unrealized —

— KINDRED BIOSCIENCES INC 1.1%

Value $4.7M Shares 689,091 Est. Cost $11.56 Unrealized —

— AVEO PHARMACEUTICALS INC 0.9%

Value $4.026M Shares 2,313,759 Est. Cost $1.84 Unrealized —

ANIP ANI PHARMACEUTICALS INC 0.4%

Value $1.924M Shares 31,000 Est. Cost $44.09 Unrealized +35.0%

— TARGACEPT INC 0.4%

Value $1.758M Shares 630,000 Est. Cost $4.63 Unrealized —

— ELEVEN BIOTHERAPEUTICS INC. 0.0%

Value $116K Shares 41,200 Est. Cost $11.87 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
—	ARIAD PHARMACEUTICALS INC	12,850,000	$106M	24.5%	$6.73	—	COM	04033A100
ABBV	ABBVIE INC.	1,580,000	$106M	24.4%	$38.85	+9.0%	COM	00287Y109
DGX	QUEST DIAGNOSTICS INC	575,000	$41.7M	9.6%	$46.05	+29.7%	COM	74834L100
—	MEDICINES CO	1,361,900	$38.96M	9.0%	$28.08	—	COM	584688105
—	AEGERION PHARMACEUTICALS INC	2,036,829	$38.64M	8.9%	$24.76	—	COM	00767E102
AMGN	AMGEN INC	200,000	$30.7M	7.1%	$104.63	+12.4%	COM	031162100
MRK	MERCK & CO INC NEW	400,000	$22.77M	5.2%	$31.29	+28.6%	COM	58933Y105
—	INTRA CELLULAR THERAPIES INC	360,000	$11.5M	2.6%	$16.06	—	COM	46116X101
—	APRICUS BIOSCIENCES INC	6,524,505	$11.16M	2.6%	$1.73	—	COM	03832V109
—	REPROS THERAPEUTICS INC	1,132,367	$8.096M	1.9%	$16.90	—	COM NEW	76028H209
—	VIVUS INC	2,573,943	$6.075M	1.4%	$9.08	—	COM	928551100
—	KINDRED BIOSCIENCES INC	689,091	$4.7M	1.1%	$11.56	—	COM	494577109
—	AVEO PHARMACEUTICALS INC	2,313,759	$4.026M	0.9%	$1.84	—	COM	053588109
ANIP	ANI PHARMACEUTICALS INC	31,000	$1.924M	0.4%	$44.09	+35.0%	COM	00182C103
—	TARGACEPT INC	630,000	$1.758M	0.4%	$4.63	—	COM	87611R306
—	ELEVEN BIOTHERAPEUTICS INC.	41,200	$116K	0.0%	$11.87	—	COM	286221106